Evaluation of cII gene mutation in the brains of Big Blue mice exposed to acrylamide and glycidamide in drinking water. 2016

Hai-Fang Li, and Sharon D Shelton, and Todd A Townsend, and Nan Mei, and Mugimane G Manjanatha
Division of Genetic and Molecular Toxicology, National Center for Toxicological Research, USA.

Potential health risks for humans from dietary exposure to acrylamide (AA) and its reactive epoxide metabolite, glycidamide (GA), exist because substantial amounts of AA are found in a variety of fried and baked starchy foods. AA is tumorigenic in rodents, and a large number of studies indicate that AA is genotoxic in multiple organs of mice and rats. Although AA is neurotoxic, there are no reports on AA-induced gene mutations in the mouse brain. Therefore, to investigate if gene mutation can be induced by AA or its metabolite GA, we screened brains for cII mutant frequency (MF) and scored for mutation types in previously treated male and female Big Blue mice with 0, 1.4 mM, and 7.0 mM AA or GA in drinking water for up to 4 weeks. High doses of AA and GA induced similar cII MFs in males and females but only the induced cII MF in males was significantly higher than the corresponding male control MF (p < 0.05). Molecular analysis of the cII mutants from males showed that AA and GA each induced at least a 2.5-fold increase in the incidence of G:C → T:A, A:T → T:A, and A:T → C:G transversions compared to the vehicle controls, with similar mutational spectra observed when comparing AA with GA treatment. These results suggest that the MFs and types of mutations induced by AA and GA in the brain are consistent with AA exerting its genotoxicity via metabolism to GA.

UI MeSH Term Description Entries
D008297 Male Males
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D009152 Mutagenicity Tests Tests of chemical substances and physical agents for mutagenic potential. They include microbial, insect, mammalian cell, and whole animal tests. Genetic Toxicity Tests,Genotoxicity Tests,Mutagen Screening,Tests, Genetic Toxicity,Toxicity Tests, Genetic,Genetic Toxicity Test,Genotoxicity Test,Mutagen Screenings,Mutagenicity Test,Screening, Mutagen,Screenings, Mutagen,Test, Genotoxicity,Tests, Genotoxicity,Toxicity Test, Genetic
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004252 DNA Mutational Analysis Biochemical identification of mutational changes in a nucleotide sequence. Mutational Analysis, DNA,Analysis, DNA Mutational,Analyses, DNA Mutational,DNA Mutational Analyses,Mutational Analyses, DNA
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004852 Epoxy Compounds Organic compounds that include a cyclic ether with three ring atoms in their structure. They are commonly used as precursors for POLYMERS such as EPOXY RESINS. Epoxide,Epoxides,Epoxy Compound,Oxiranes,Compound, Epoxy,Compounds, Epoxy
D005260 Female Females
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

Hai-Fang Li, and Sharon D Shelton, and Todd A Townsend, and Nan Mei, and Mugimane G Manjanatha
June 2015, Environmental and molecular mutagenesis,
Hai-Fang Li, and Sharon D Shelton, and Todd A Townsend, and Nan Mei, and Mugimane G Manjanatha
January 2006, Environmental and molecular mutagenesis,
Hai-Fang Li, and Sharon D Shelton, and Todd A Townsend, and Nan Mei, and Mugimane G Manjanatha
September 2010, Toxicological sciences : an official journal of the Society of Toxicology,
Hai-Fang Li, and Sharon D Shelton, and Todd A Townsend, and Nan Mei, and Mugimane G Manjanatha
June 2010, Toxicological sciences : an official journal of the Society of Toxicology,
Hai-Fang Li, and Sharon D Shelton, and Todd A Townsend, and Nan Mei, and Mugimane G Manjanatha
January 2012, Journal of toxicology and environmental health. Part A,
Hai-Fang Li, and Sharon D Shelton, and Todd A Townsend, and Nan Mei, and Mugimane G Manjanatha
August 2015, Mutation research. Genetic toxicology and environmental mutagenesis,
Hai-Fang Li, and Sharon D Shelton, and Todd A Townsend, and Nan Mei, and Mugimane G Manjanatha
February 2005, Toxicology and applied pharmacology,
Hai-Fang Li, and Sharon D Shelton, and Todd A Townsend, and Nan Mei, and Mugimane G Manjanatha
January 1999, Environmental and molecular mutagenesis,
Hai-Fang Li, and Sharon D Shelton, and Todd A Townsend, and Nan Mei, and Mugimane G Manjanatha
September 2000, Mutation research,
Hai-Fang Li, and Sharon D Shelton, and Todd A Townsend, and Nan Mei, and Mugimane G Manjanatha
September 1998, Mutagenesis,
Copied contents to your clipboard!